Northwestern Mutual Wealth Management
SRPT icon

Northwestern Mutual Wealth Management’s Sarepta Therapeutics SRPT Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.4K Buy
248
+200
+417% +$3.87K ﹤0.01% 3285
2025
Q4 		$1.03K Hold
48
– – ﹤0.01% 3620
2025
Q3 		$925 Hold
48
– – ﹤0.01% 3561
2025
Q2 		$821 Sell
48
-271
-85% -$11.6K ﹤0.01% 3410
2025
Q1 		$20.4K Buy
319
+144
+82% +$15.2K ﹤0.01% 2505
2024
Q4 		$21.3K Sell
175
-34
-16% -$4.17K ﹤0.01% 2489
2024
Q3 		$26.1K Sell
209
-41
-16% -$5.67K ﹤0.01% 2374
2024
Q2 		$39.5K Buy
250
+200
+400% +$25.7K ﹤0.01% 2169
2024
Q1 		$6.47K Buy
+50
New +$6.13K ﹤0.01% 2768
2023
Q3 		– Sell
-7
Closed -$802 – 3520
2023
Q2 		$802 Buy
+7
New +$903 ﹤0.01% 3119
2022
Q4 		– Sell
-10
Closed -$1K – 3465
2022
Q3 		$1K Buy
+10
New +$1.01K ﹤0.01% 3016
2022
Q2 		– Sell
-2
Closed – – 3458
2022
Q1 		$0 Buy
+2
New +$153 ﹤0.01% 3381
2021
Q4 		– Sell
-55
Closed -$5K – 3326
2021
Q3 		$5K Buy
+55
New +$4.24K ﹤0.01% 2681
2021
Q1 		– Sell
-635
Closed -$108K – 2959
2020
Q4 		$108K Hold
635
– – ﹤0.01% 1375
2020
Q3 		$89K Hold
635
– – ﹤0.01% 1319
2020
Q2 		$102K Buy
635
+633
+31,650% +$86.1K ﹤0.01% 1202
2020
Q1 		$0 Sell
2
-2
-50% -$229 ﹤0.01% 2737
2019
Q4 		$1K Buy
+4
New +$404 ﹤0.01% 2331
2019
Q2 		– Sell
-3
Closed – – 2697
2019
Q1 		$0 Sell
3
-70
-96% -$9K ﹤0.01% 2693
2018
Q4 		$8K Buy
+73
New +$9.13K ﹤0.01% 1906
2016
Q3 		– Sell
-1,000
Closed -$19K – 1350
2016
Q2 		$19K Buy
+1,000
New +$18.5K ﹤0.01% 1189

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northwestern Mutual Wealth Management's SRPT Position: Q1 2026 in Review

Northwestern Mutual Wealth Management increased its Sarepta Therapeutics (SRPT) stake by 417% in Q1 2026, buying an estimated $3.87K and bringing the position to 248 shares worth $5.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3285.

Northwestern Mutual Wealth Management first reported a position in SRPT in Q2 2016 and has held it in 21 quarters since. The position peaked at $108K in Q4 2020. 341 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • Northwestern Mutual Wealth Management held 248 shares of Sarepta Therapeutics worth $5.4K as of Q1 2026.
  • Northwestern Mutual Wealth Management bought 200 Sarepta Therapeutics shares in Q1 2026, an estimated $3.87K.
  • Sarepta Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3285 holding.
  • Northwestern Mutual Wealth Management first reported a position in Sarepta Therapeutics in Q2 2016 and has held it in 21 quarters since.
  • Northwestern Mutual Wealth Management's Sarepta Therapeutics position peaked at $108K in Q4 2020.
  • 341 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.